Skip to main content

Life Sciences

Is Risk-Based Monitoring Compliant?



When we think of compliance, we think of consistency. Compliance depends on following the same processes and procedures over and over, across the board. After all, that’s why we have all of those SOPs, right?

When we’re used to conceptualizing compliance this way, the notion of risk-based monitoring can certainly lead to cognitive dissonance. RBM means that the monitoring process is different for each study AND for individual sites within a study. How can something that seems so inconsistent possibly be compliant? 

Well, in an RBM strategy, the consistency is definitely still present; it’s just based on a complex set of criteria that’s unique to each study, rather than on generalizations. In the risk assessment performed during study planning, the risks specific to the study are identified. After that, a monitoring plan is developed that mitigates those specific risks.

It’s important to understand that, even though all sites within an RBM study are not being treated/monitored equally, the monitoring process itself is still consistent. The sites that meet the same study-specific criteria are monitored the same way, which makes it compliant.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Marin Richeson

Marin joined the life sciences industry in 2001. Over the course of her tenure, she has held roles in clinical finance, IT, quality assurance, and validation. The diversity of her experience provides her with a unique perspective on the interconnectedness of this complex, multi-faceted industry. Marin Richeson is a lead business consultant in Perficient's life sciences practice.

More from this Author

Follow Us